Positive Effects of Haematococcus Astaxanthin on Oxidative Stress and Lipid Profile in Overweight and Obese Adults
1 other identifier
interventional
30
1 country
1
Brief Summary
The purpose of this study is to determine whether astaxanthin (ASX) supplementation will reduce obesity-induced oxidative stress and improve lipid profile in overweight and obese adults.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable healthy
Started Aug 2010
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 8, 2010
CompletedFirst Posted
Study publicly available on registry
July 22, 2010
CompletedStudy Start
First participant enrolled
August 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2011
CompletedJuly 22, 2010
July 1, 2010
4 months
July 8, 2010
July 20, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Evaluation of the plasma MDA (malonaldehyde) level
MDA is a three chain aldehyde produced during the composition of a lipid hydroperoxide and is a well known indicator of lipid peroxidation. The purpose of this stduy is to determine whether ASX supplementation lowers oxidative stress using MDA,a biomarker.
12 weeks
Interventions
astaxanthin 20mg for 12 weeks
Eligibility Criteria
You may qualify if:
- Subjects with BMI over 25.0 kg/m2
- Non-smoker
You may not qualify if:
- Excessive alcohol consumption
- Pregnant or lactating women
- Dyslipidemia, hyperglycemia, or other chronic diseases.
- Subjects who were taking vitamin supplements
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Clinical Research Institute Seoul National University Hospital
Seoul, Seoul, 110-744, South Korea
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 8, 2010
First Posted
July 22, 2010
Study Start
August 1, 2010
Primary Completion
December 1, 2010
Study Completion
March 1, 2011
Last Updated
July 22, 2010
Record last verified: 2010-07